ArticleClinical and translational medicine2025

A new peptide inhibitor of C1QBP exhibits potent anti-tumour activity against triple negative breast cancer by impairing mitochondrial function and suppressing homologous recombination repair.

Xingxing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.